Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Isabel Lucena

Showing results (111-120 of 152) with videos related to

Pageof 16
Sort By:
Hepatology (Baltimore, Md.)|May 29, 2009
Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sexM Isabel Lucena, Raúl J Andrade, Neil Kaplowitz, et al.
Gastroenterology|April 29, 2019
Endoplasmic Reticulum Stress-Induced Upregulation of STARD1 Promotes Acetaminophen-Induced Acute Liver FailureSandra Torres, Anna Baulies, Naroa Insausti-Urkia, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injuryM Isabel Lucena, Elena García-Martín, Raúl J Andrade, et al.
Acta Pharmaceutica Sinica. B|June 29, 2026
Systematic review on genetic polymorphisms associated with idiosyncratic drug-induced liver injury (iDILI): iDILInet as an interactive visualization toolGonzalo Matilla-Cabello, Ángela Remesal-Doblado, Muazzez Celebi-Cinar, et al.
Pharmacogenetics and Genomics|May 21, 2016
Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen allelesCamilla Stephens, Agustin Castiella, Eva M Gomez-Moreno, et al.
Pharmacological Research|December 10, 2023
Prior drug allergies are associated with worse outcome in patients with idiosyncratic drug-induced liver injury: A machine learning approach for risk stratificationHao Niu, Pablo Solis-Muñoz, Miren García-Cortés, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2015
The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicityMercedes Robles-Diaz, Miren Garcia-Cortes, Inmaculada Medina-Caliz, et al.
Archives of Toxicology|November 23, 2022
Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registriesFernando Bessone, Antonella Ferrari, Nelia Hernandez, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registryRaúl J Andrade, M Isabel Lucena, Neil Kaplowitz, et al.
Clinical Pharmacology and Therapeutics|November 2, 2020
Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug RegimensPaola Nicoletti, Harshad Devarbhavi, Ashish Goel, et al.
Pageof 16

Showing results (111-120 of 152) with videos related to

Sort By:
Pageof 16
Hepatology (Baltimore, Md.)|May 29, 2009
Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sexM Isabel Lucena, Raúl J Andrade, Neil Kaplowitz, et al.
Gastroenterology|April 29, 2019
Endoplasmic Reticulum Stress-Induced Upregulation of STARD1 Promotes Acetaminophen-Induced Acute Liver FailureSandra Torres, Anna Baulies, Naroa Insausti-Urkia, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injuryM Isabel Lucena, Elena García-Martín, Raúl J Andrade, et al.
Acta Pharmaceutica Sinica. B|June 29, 2026
Systematic review on genetic polymorphisms associated with idiosyncratic drug-induced liver injury (iDILI): iDILInet as an interactive visualization toolGonzalo Matilla-Cabello, Ángela Remesal-Doblado, Muazzez Celebi-Cinar, et al.
Pharmacogenetics and Genomics|May 21, 2016
Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen allelesCamilla Stephens, Agustin Castiella, Eva M Gomez-Moreno, et al.
Pharmacological Research|December 10, 2023
Prior drug allergies are associated with worse outcome in patients with idiosyncratic drug-induced liver injury: A machine learning approach for risk stratificationHao Niu, Pablo Solis-Muñoz, Miren García-Cortés, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2015
The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicityMercedes Robles-Diaz, Miren Garcia-Cortes, Inmaculada Medina-Caliz, et al.
Archives of Toxicology|November 23, 2022
Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registriesFernando Bessone, Antonella Ferrari, Nelia Hernandez, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registryRaúl J Andrade, M Isabel Lucena, Neil Kaplowitz, et al.
Clinical Pharmacology and Therapeutics|November 2, 2020
Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug RegimensPaola Nicoletti, Harshad Devarbhavi, Ashish Goel, et al.
Pageof 16